X
The Russell Group uses a robust evidence base to ensure that the Government and policy makers are able to make informed decisions.
Scroll down to see our latest policy papers.
Our universities are global leaders in research, but it is vital they receive sufficient funding and support
Read more >A high-quality, research-led education requires proper funding at both undergraduate and postgraduate level
Read more >The under-representation of talented students from certain backgrounds has deep-rooted causes which we cannot solve alone
Read more >Collaboration with business is a key part of the work of our universities but Government could foster more innovation
Read more >Our universities are global businesses competing for staff, students and funding with the best in the world
Read more >Autonomy is crucial to the success of our universities – they will not flourish if they are over-regulated
Read more >
This report and toolkit examines the current UK academic research culture and environment, including the system drivers and incentives which can create challenges and unintended consequences for researchers. The report is based on conversations and interviews with almost 100 representatives from universities (including researchers at all career stages), funders and publishers.
Read more >
This report sets out a roadmap to tackle educational inequality, laying out reasons why a national strategy is required and looking at how Russell Group universities, together with the Government and regulators, can unleash the potential of students across the country, whatever their background.
Read more >
Genome sequencing technology developed at Cambridge has generated an annual turnover of over £750 million from an initial public investment in basic research of only £274,196. This means that for every £1 of public investment, the research now delivers £2,735 every year, even without counting the wider economic and social benefits.
Read more >
Antibiotic resistance is a major global concern and, according to the UK Chief Medical Officer, poses a threat equivalent to terrorism. Yet investment in antibiotics R&D is low due to a lack of economic incentives. Researchers at LSE analysed the incentives needed to get antibiotics R&D going again.
Read more >
